Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Northside Hospital and Heart Institute
mi
from
St. Petersburg, FL
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Northside Hospital and Heart Institute
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
University Community Hospital
mi
from
Tampa, FL
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
University Community Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Redmond Regional Medical Center
mi
from
Rome, GA
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Redmond Regional Medical Center
mi
from
Rome, GA
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Kootenai Medical Center
mi
from
Coeur d'Alene, ID
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Kootenai Medical Center
mi
from
Coeur d'Alene, ID
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Krannert Institute of Cardiology
mi
from
Indianapolis, IN
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Krannert Institute of Cardiology
mi
from
Indianapolis, IN
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
The Indiana Heart Hospital
mi
from
Indianapolis, IN
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
The Indiana Heart Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Iowa Heart Center, P.C.
mi
from
West Des Moines, IA
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Iowa Heart Center, P.C.
mi
from
West Des Moines, IA
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
King's Daughters Medical Center - Kentucky Heart Inst
mi
from
Ashland, KY
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
King's Daughters Medical Center - Kentucky Heart Inst
mi
from
Ashland, KY
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Maine Medical Center
mi
from
Portland, ME
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Maine Medical Center
mi
from
Portland, ME
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Union Memorial Hospital
mi
from
Baltimore, MD
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Union Memorial Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Tufts Medical Center
mi
from
Boston, MA
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Sparrow Health System - Sparrow Hospital
mi
from
Lansing, MI
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Sparrow Health System - Sparrow Hospital
mi
from
Lansing, MI
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Northern Michigan Hospital
mi
from
Petoskey, MI
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Northern Michigan Hospital
mi
from
Petoskey, MI
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Lakeland Hospitals at St. Joseph
mi
from
St. Joseph, MI
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Lakeland Hospitals at St. Joseph
mi
from
St. Joseph, MI
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Memorial Hospital at Gulfport
mi
from
Gulfport, MS
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Memorial Hospital at Gulfport
mi
from
Gulfport, MS
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Freeman West Hospital
mi
from
Joplin, MO
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Freeman West Hospital
mi
from
Joplin, MO
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Our Lady of Lourdes Medical Center
mi
from
Haddon Heights, NJ
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Our Lady of Lourdes Medical Center
mi
from
Haddon Heights, NJ
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Jersey Shore University Medical Center
mi
from
Sea Girt, NJ
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Jersey Shore University Medical Center
mi
from
Sea Girt, NJ
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
St. Joseph's Hospital Health Center
mi
from
Liverpool, NY
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
St. Joseph's Hospital Health Center
mi
from
Liverpool, NY
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
St. Elizabeth Medical Center
mi
from
Utica, NY
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
St. Elizabeth Medical Center
mi
from
Utica, NY
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Wake Medical Center
mi
from
Raleigh, NC
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Wake Medical Center
mi
from
Raleigh, NC
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Ohio State University Medical Center
mi
from
Columbus, OH
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Riverside Methodist Hospital
mi
from
Columbus, OH
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Mercy St. Vincent Medical Center
mi
from
Toledo, OH
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Mercy St. Vincent Medical Center
mi
from
Toledo, OH
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
St. Mary Medical Center
mi
from
Yardley, PA
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
St. Mary Medical Center
mi
from
Yardley, PA
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Sisters of Charity Providence Hospital
mi
from
Columbia, SC
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Sisters of Charity Providence Hospital
mi
from
Columbia, SC
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Grand Strand Regional Medical Center
mi
from
Myrtle Beach, SC
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Grand Strand Regional Medical Center
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Regional Hospital
mi
from
Jackson, TN
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Regional Hospital
mi
from
Jackson, TN
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Centennial Medical Center
mi
from
Nashville, TN
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Centennial Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
CRSTI/Medical City Dallas
mi
from
Dallas, TX
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
CRSTI/Medical City Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Kingwood Medical Center Hospital
mi
from
Kingwood, TX
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Kingwood Medical Center Hospital
mi
from
Kingwood, TX
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Methodist Texsan Hospital
mi
from
San Antonio, TX
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Methodist Texsan Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Meriter Hospital, Inc.
mi
from
Madison, WI
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Meriter Hospital, Inc.
mi
from
Madison, WI
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
CaRE Foundation, Inc
mi
from
Wausau, WI
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
CaRE Foundation, Inc
mi
from
Wausau, WI
Click here to add this to my saved trials
Identification of Genetic Markers for Cardiopulmonary Diseases (Genotype)
Identification of Genetic Markers for Cardiopulmonary Diseases
Status: Enrolling
Updated:  1/7/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Identification of Genetic Markers for Cardiopulmonary Diseases (Genotype)
Identification of Genetic Markers for Cardiopulmonary Diseases
Status: Enrolling
Updated: 1/7/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Mobile Heart Specialists, PC
mi
from
Mobile, AL
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Mobile Heart Specialists, PC
mi
from
Mobile, AL
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Silicon Valley Medical Imaging
mi
from
Fremont, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Silicon Valley Medical Imaging
mi
from
Fremont, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Westside Medical Associates of Los Angeles
mi
from
Los Angeles, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Westside Medical Associates of Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Ventura Clinical Trials
mi
from
Malibu, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Ventura Clinical Trials
mi
from
Malibu, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Mission Internal Medical Group
mi
from
Mission Viejo, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Mission Internal Medical Group
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
VA San Diego Healthcare System
mi
from
San Diego, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
VA San Diego Healthcare System
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Santa Rosa Cardiology Medical Group, Inc.
mi
from
Santa Rosa, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Santa Rosa Cardiology Medical Group, Inc.
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
HOCC - New Britain Campus
mi
from
New Britain, CT
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
HOCC - New Britain Campus
mi
from
New Britain, CT
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Yale University
mi
from
New Haven, CT
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials